ABEONA THERAPEUTICS INC. — Income Charts
63 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$5M
Cost of Revenue
$1M
R&D↓-25.4% -$2M
$7M
SG&A↑+144.6% +$11M
$19M
D&A↑+60.1% +$324K
$863K
Operating Income↓-56.5% -$9M
$-24M
EBITDA↑+60.1% +$324K
$863K
Interest Expense↓-18.3% -$198K
$884K
Interest Income↑+51.2% +$524K
$2M
Other Income/Expense↑+119.2% +$18M
$3M
Pretax Income↑+32.7% +$10M
$-20M
Tax Provision
$-15M
Net Income↑+82.9% +$25M
$-5M
Operating Margin
-5698.0%
Net Margin
27208.3%
Effective Tax Rate
74.6%
ETR (Continuing Operations)
0.1%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
0.0%
Operating Lease Cost↓-15.9% -$50K
$264K
Revenue YoY Variation
-100.0%
Income YoY Variation↓-21.1pts
-56.5%
Revenue QoQ Variation
-100.0%
Income QoQ Variation↓-19.5pts
-5.4%